MergerLinks Header Logo

Request Deal Involvement

Mylan completed the merger with Pfizer's off-patent medicines unit.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Centerview Partners

financial advisors

Centerview Partners

Cravath Swaine & Moore

legal advisors

Cravath Swaine & Moore

NautaDutilh

legal advisors

NautaDutilh

Fangda Partners

legal advisors

Fangda Partners

PJT Partners

financial advisors

PJT Partners

Wilson Sonsini Goodrich & Rosati

legal advisors

Wilson Sonsini Goodrich & Rosati

Stibbe

legal advisors

Stibbe

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Goldman Sachs

financial advisors

Goldman Sachs

Guggenheim Partners

financial advisors

Guggenheim Partners

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

De Brauw Blackstone Westbroek

legal advisors

De Brauw Blackstone Westbroek

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Citigroup

financial advisors

Citigroup

Clifford Chance

legal advisors

Clifford Chance

Ciftci Law

legal advisors

Ciftci Law

or

Principals

MYLAN NV

bidder

MYLAN NV

PFIZER INC

vendor

PFIZER INC

UPJOHN

target

UPJOHN

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite